Navigation Links
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
Date:7/14/2008

. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit http://www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx(TM) are trademarks of Cardium
Therapeutics, Inc. Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM)

are trademarks of Tissue Repair Company. InnerCool Therapies(R), InnerCool(R), Celsius Control System(R),

RapidBlue(TM), CoolBlue(TM). Accutrol(R), Temperature Control Element(R) and

TCE(R) are trademarks of InnerCool Therapies, Inc.


'/>"/>
SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cardium Announces Follow-On Direct Investment by Institutional Investor
2. Cardium Selected for Inclusion in Russell Microcap Index
3. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardium Launches New AWARE Clinical Study Website
5. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
6. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
9. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
10. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
11. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...re-FirstCall/--Sigma-AldrichCorporation(Nasdaq: SI...day,December1stat1:45PMGMTinLondon,7:45AMUS/CST.In...heInternetavailableat http://inve s tor.sig m ...toaccessthisfile. ,, AboutSigma-Aldrich: Sig...mpany.Itschemicalandbiochemicalproductsandkitsareu...
(Date:11/24/2009)...RNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ...ommercializingnovelpainmanagementtherapies,announc...veOfficer,isscheduledtopresentatthe21stAnnualPiper...09atTheNewYorkPalaceHotelinNewYork,NewYork. ,, ...r,willbeavailabletorespondtoquestionsduringthepres...
(Date:11/24/2009)...asbeenmetforpatientswithadvanced-stage,orrecurrent...wire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;...panyfocusedonendocrinetherapyandoncology,todayanno...rgetedcytotoxicpeptideconjugate,AEZS-108(formerlyA...lcancer.Inapersonalizedhealthcareapproach,thestudy...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq...,sExecutiveChairman,willpresentatthe21stAnnualPipe...,December1,2009at10:00a.m.ET. ,, Toaccesstheliv...isittheInvestorRelationssectionofGenomicHealth,swe...onnecttothewebsiteatleast15minutespriortothebeginn...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...FRANCISCO, March 12 VIA Pharmaceuticals, Inc. (Na... the development of compounds for the treatment of...nced it has entered into a $10.0 million secured n...llary agreements, the "Loan Agreement") with Bay C...s (collectively, "Lender"), the Company,s principa...
... A significant challenge utili... the cost and uncertainty associated with vectors ...roblem, DNA2.0 has developed a new family of vecto...s. pJexpress vectors are specifically engineered t...own to express better than comparable pET vectors....
...ADELPHIA, March 12 ERT, a leading provider of cen...ther services to the biopharmaceutical, medical de... it will be showcasing its portfolio of products a... DIA Euromeeting, 23-25 March 2009 in Berlin, Germ...ing sessions, which will discuss the impact of tec...
Other Biology Technology:VIA Pharmaceuticals Secures Financing Up to $10.0 Million 2VIA Pharmaceuticals Secures Financing Up to $10.0 Million 3VIA Pharmaceuticals Secures Financing Up to $10.0 Million 4DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 2DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors 3ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 2ERT to Showcase Its Clinical Trials Portfolio at DIA's 21st Euromeeting 3
(Date:11/24/2009)...RK (November 24, 2009) -- The Wildlife Conservatio... that the last remaining population of Siberian ti...rising tide of poaching and habitat loss. , ...an officials of what needs to be done to protect r..., The report was released by the Sib...
(Date:11/23/2009)... presents strong evidence that the "synergistic" e...ic-related pollution and indoor endotoxin causes m... exposure alone. , Environmental health scient...of Medicine have shown that children exposed to bo...door endotoxin during early life are six times mor...
(Date:11/23/2009)... than 160 participants gathered this week for the ...TIATIVE conference. This year,s topic, "Synthetic ...and medical researchers to explore the engineering...erging field of synthetic biology. , Bonnie L. B...n University and this year,s conference chair, cha...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 1Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 2Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 3Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 4Majority of Public Maintains Support for Addressing Health Care Reform Now 52480 5KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 1KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 2KLOS 26 Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 52478 3E Cigarettes Pose a Health Hazard FDA Warns 52474 1E Cigarettes Pose a Health Hazard FDA Warns 52474 2E Cigarettes Pose a Health Hazard FDA Warns 52474 3
...rs at the UC Davis M.I.N.D. Institute has found th... children born in California with autism since 199... condition is diagnosed or counted and the trend ...ary 2009 issue of the journal Epidemiology , resu...ld shift from genetics to the host of chemicals an...
...nal that publishes original research contributions... of entomology, plant pathology, virology, nematol...gicides, herbicides and other biocides. Emphasis ...iseases. , Phytoparasitica also publishes invit...t editorials written by reputable scientists attes...
... Prevention Research , a journal of the American A...nts of black raspberries with chemopreventive pote...ive Cancer Center found that anthocyanins, a class...wth and stimulated apoptosis in the esophagus of r...r data provide strong evidence that anthocyanins a...
Other Biology News:Study shows California's autism increase not due to better counting, diagnosis 2Study shows California's autism increase not due to better counting, diagnosis 3Springer expands its portfolio in plant sciences with Phytoparasitica 2
Uniblot accessories from Sigma-Aldrich
StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
Aquarius 384 Multichannel Pipettor from Tecan
...nx software, a multitasking application capable of...amming and operation of lab automation workcells e...tom modification by programmers. • Users cr...wchart. If you can build a flowchart, you can writ...
Biology Products: